Compounds that bind to pnpla3i148m and their use in treating liver diseases
CO20260008815A2Pending Publication Date: 2026-06-30NOVARTIS AG
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- CO · CO
- Patent Type
- Applications
- Current Assignee / Owner
- NOVARTIS AG
- Filing Date
- 2026-06-16
- Publication Date
- 2026-06-30
Abstract
The invention relates to compounds of Formula (I), and pharmaceutically acceptable salts and isomers of said compounds, which bind to the patatin-like phospholipidase domain-containing protein 3 (PNPLA3) mutation PNPLA3I148M, (I) pharmaceutical compositions comprising a compound of Formula (I), or pharmaceutically acceptable salts thereof, and their use in methods for the treatment of diseases associated with PNPLA3I148M.
Need to check novelty before this filing date? Find Prior Art